Adverse Drug Reactions and Interactions in Antibiotic Therapy: Allergic Reactions

L.V. Bohun, I.H. Berezniakov

Abstract


.

References


Asscher A.W., Parr G.D., Whitmarsh V.B. Towards the safer use of medicines // BMJ. — 1995. — 311. — 1003-1005.

Bates D.W., Spell N., Cuilen D.J., Burdick E., Laird N., Petersen L.A. et al. The costs of adverse drug events in hospitalized patients // JAMA. — 1997. — 277. — 307-311.

Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F., Burke J.P. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality // JAMA. —1997. — 277. — 301-306.

Einarson T.R. Drug-related hospital admissions // Ann. Pharmacother. — 1993. — 27. — 832-840.

Park B.K., Pirmohamed M., Kitteringham N.R. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors // Br. J. Clin. Pharmacol. — 1992. — 34. — 377-395.

Bigby M., Jick S., Jick H., Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 // JAMA. — 1986. — 256. — 3358-3363.

Park B.K., Coleman J.W., Kitteringham N.R. Drug disposition and drug hypersensitivity // Biochem. Pharmacol. — 1987. —36. — 581-590.

Gruchalla R.S., Pirmohamed M. Antibiotic allergy // N. Engl. J. Med. —2006. — 354. — 601-609.

Janeway C., Travers C., Walport M., Shlomchik M., Immunology: The Immune System in Health and Disease. — 5th ed. — New York: Garland, 2001.

Smith J.W., Johnson J.E. III, Cluff L.E. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy // N. Engl. J. Med. — 1966. — 274. —998-1002.

DeSwarte R.D., Patterson R. Drug allergy // Allergic di-seases: diagnosis and management / Еd. by R. Patterson, L.C. Grammer, P.A. Greenberger. — 5th ed. — Philadelphia: Lippincott–Raven, 1997. — 317-412.

Pirmohamed M., Park B.K. HIV and drug allergy // Curr. Opin. Allergy Clin. Immunol. — 2001. — 1. — 311-316.

Mori K., Maru C., Takasuna K. Char acterization of histamine release induced by fluoroquinolone antibacterial agents in vivo and in vitro // J. Pharm. Pharmacol. — 2000. — 52. — 577-584.

Veien M., Szlam F., Holden J.T., Yamaguchi K., Denson D.D., Levy J.H. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells // Anesthesiology. — 2000. — 92. — 1074-1081.

Lee C.E., Zembower T.R., Fotis M.A. et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacte rial resistancе // Arch. Intern. Med. — 2000. — 160. — 2819-2822.

Pirmohamed M., Breckenridge A.M., Kitteringham N.R., Park B.K. Adverse drug reactions // BMJ. — 1998. — 316. — 1295-1298.

Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs // N. Engl. J. Med. — 1994. — 331. — 1272-1285.

Sullivan J.R., Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis? // Arch. Dermatol. — 2001. — 137. — 357-364.

Pirmohamed M., Kitteringham N.R., Park B.K. The role of active metabolites in drug toxicity // Drug. Saf. — 1994. — 11. — 114-144.

Rudolph A.H., Price E.V. Penicillin reactions among patients in venereal disease clinics: a national survey // JAMA. — 1973. — 223. — 499-501.

Pirmohamed M., Breckenridge A.M., Kitteringham N.R., Park B.K. Adverse drug reactions // BMJ. — 1998. — 316. — 1295-1298.

Empedrad R., Darter A.L., Earl H.S., Gruchalla R.S. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics // J. Allergy Clin. Immunol. — 2003. — 112. — 629-630.

Bernstein I., Gruchalla R.S., Lee R., Nicklas R., Dykewicz M. Executive summary of disease management of drug hypersensitivity: a practice parameter // Ann. Allergy Asthma Immunol. — 1999. — 83. — 665-700.

Gadde J., Spence M., Wheeler B., Adkinson N.F. Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic // JAMA. — 1993. — 270. — 2456-2463.

Macy E., Mangat R., Burchette R.J. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins // J. Allergy Clin. Immunol. — 2003. — 111. — 1111-1115.

Malakar S., Dhar S., Shah Malakar R. Is serum sickness an uncommon adverse effect of minocycline treatment? // Arch. Dermatol. — 2001. — 137. — 100-101.

Pichler W.J., Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity // Allergy. — 2004. — 59. — 809-820.

Messaad D., Sahla H., Benahmed S., Godard P., Bousquet J., Demoly P. Drug provocation tests in patients with a history sug gesting an immediate drug hypersensitivity reaction // Ann. Intern. Med. — 2004. — 140. — 1001-1006.

Страчунский Л.С., Рафальский В.В. Аллергические реакции на антибиотики. Методическое пособие www.antibiotic.ru/rus/all/metod/aballergy/02.shtml#4

Papakonstantinou G., Bogner J.R., Hofmeister F., Hehlmann R. Cefotaxime desensitization // Clin. Investig. — 1993. — 71. — 165-167.

Ghosal S., Taylor C.J. Intravenous de sensitization to ceftazidime in cystic fibrosis patients // J. Antimicrob. Chemother. — 1997. — 39. — 556-557.

Naclerio R., Mizrahi E., Adkinson N.F. Jr. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin // J. Allergy Clin. Immunol. — 1983. — 71. — 294-301.

Turvey S.E., Cronin B., Arnold A.D., Dioun A.F. Antibiotic desensitization for the allergic patient: 5 years of experience and practice // Ann. Allergy Asthma Immunol. — 2004. — 92. — 426-432.

Burrows J.A., Toon M., Bell S.C. Antibiotic desensitization in adults with cystic fibrosis // Respirology. — 2003. — 8. —359-364.

Rich J.D., Sullivan T., Greineder D., Kazanjian P.H. Trimethoprim/sulfamethoxazole incremental dose regimen in human im munodeficiency virus-infected persons // Ann. Allergy Asthma Immunol. — 1997. — 79. — 409-414.

Zeok S.S., Tsueda K. Failure of a cephalothin test dose to produce anaphylaxis // Anesth. Analg. — 1980. — 59. — 393-394.

Saxon A., Beall G.N., Rohr A.S., Adelman D.C. Immediate hypersensitivity reactions to beta-lactam antibiotics // Ann. Intern. Med. — 1987. — 107. — 204-215.

Hamilton-Miller J.M., Abraham E.P. Specificities of haemagglutinating antibodies evoked by members of the cephalosporin C family and benzylpenicillin // Biochem. J. — 1971. — 123. — 183-190.

Batchelor F.R., Dewdney J.M., Weston R.D., Wheeler A.W. The immunogenicity of cephalosporin derivatives and their cross-reaction with penicillin // Immunology. — 1966. — 10. — 21-33.

Kelkar P.S., Li J.T.-C. Cephalosporin Allergy // N. Engl. J. Med. — 2001. — 345. — 804-809.

Mendelson L.M. Adverse reactions to β-lactam antibiotics // Immunol. Allergy Clin. North. Am. — 1998. — 18. — 745-57.

Практическое руководство по антиинфекционной химиотерапии / Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. — М.: Боргес, 2002. — 384 с.

Brackett C.C., Singh H., Block J.H. Likelihood and mechanisms of cross-allerge nicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group // Pharmacotherapy. — 2004. — 24. — 856-870.

Strom B., Schinnar R., Apter A. et al. Absence of cross-reacti-vity between sulfonamide antibiotics and sulfonamide nonantibiotics // N. Engl. J. Med. — 2003. — 349. — 1628-1635.




DOI: https://doi.org/10.22141/2224-0586.7.70.2015.78745

Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта